A review of vaccine clinical trials for non-small cell lung cancer

By Nemunaitis J   Nemunaitis J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 89-102

Informa Healthcare

Access to resources Recommend Favorite

Tuberculosis vaccine development: research, regulatory and clinical strategies

By Brennan Michael J   Morris Sheldon L   Sizemore Christine F  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1493-1504

Informa Healthcare

Access to resources Recommend Favorite

On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development

By Lowe P. J.   Hijazi Y.   Luttringer O.   Yin H.   Sarangapani R.   Howard D.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1331-1354

Informa Healthcare

Access to resources Recommend Favorite

Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials

By  

Current Proteomics, Vol. 10, Iss. 2, 2013-07 ,pp. : 150-164

Bentham Science Publishers

Access to resources Recommend Favorite

Large-Scale Purification and Characterization of Malaria Vaccine Candidate Antigen Pvs25H for Use in Clinical Trials

By Miles A.P.   Zhang Y.   Saul A.   Stowers A.W.  

Protein Expression and Purification, Vol. 25, Iss. 1, 2002-06 ,pp. : 87-96

Academic Press

Access to resources Recommend Favorite